Key result
Nationwide trends in Australia from 1993 to 2017 showed annual MI incidence peaked at 270.4 cases per 100,000 in 2007 and declined to 218.7 in 2017, with STEMI decreasing and NSTEMI increasing.
Why the study?
Prior data showed rising acute MI trends in Australia, but whether these increases continued in recent years was unknown.
Observational
Yes
In Australia, MI hospitalisation rates peaked in 2007 and have since stabilized, characterized by a shift from STEMI to NSTEMI and increasing use of PCI.
MI incidence stabilized in Australia with NSTEMI rise; extends long-term trends but leaves open subtype drivers.
OBJECTIVE: Prior data have shown rising acute myocardial infarction (MI) trends in Australia; whether these increases have continued in recent years is not known. This study thus sought to characterise contemporary nationwide trends in MI hospitalisations and coronary procedures in Australia and their associated economic burden. METHODS: The primary outcome measure was the incidence and time trends of total MI, ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) hospitalisations from 1993 to 2017. The incidence and time trends of coronary procedures were additionally collected, alongside MI hospitalisation costs. RESULTS: Adjusted for population changes, annual MI incidence increased from 216.2 cases per 100 000 to a peak of 270.4 in 2007 with subsequent decline to 218.7 in 2017. Similarly, NSTEMI incidence increased from 68.0 cases per 100 000 in 1993 to a peak of 192.6 in 2007 with subsequent decline to 162.6 in 2017. STEMI incidence decreased from 148.3 cases per 100 000 in 1993 to 56.2 in 2017. Across the study period, there were annual increases in MI hospitalisations of 0.7% and NSTEMI hospitalisations of 5.6%, and an annual decrease in STEMI hospitalisations of 4.8%. Angiography and percutaneous coronary intervention increased by 3.4% and 3.3% annually, respectively, while coronary artery bypass graft surgery declined by 2.2% annually. MI hospitalisation costs increased by 100% over the study period, despite a decreased average length of stay by 45%. CONCLUSIONS: The rising incidence of MI hospitalisations appear to have stabilised in Australia. Despite this, associated healthcare expenditure remains significant, suggesting a need for continual implementation of public health policies and preventative strategies.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2022) conducted an observational in Myocardial infarction. Nationwide trends in Australia from 1993 to 2017 showed annual MI incidence peaked at 270.4 cases per 100,000 in 2007 and declined to 218.7 in 2017, with STEMI decreasing and NSTEMI increasing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: